featured
Durability of Neutralizing RSV Antibodies Following Nirsevimab Administration and Elicitation of the Natural Immune Response to RSV Infection in Infants
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants
Nat. Med. 2023 Apr 24;[EPub Ahead of Print], D Wilkins, Y Yuan, Y Chang, AA Aksyuk, BS Núñez, U Wählby-Hamrén, T Zhang, ME Abram, A Leach, T Villafana, MT EsserFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.